Multi-Modal Anesthesia Protocol in Pain Management of Patients Undergoing Posterior Lumbar Spinal Fusion Surgery

• Status: Completed
• Trial end date: 2022-03-23
• Target enrollment: 0
• Participant gender: All

Summary

This study consisted of a randomized controlled trial designed to evaluate a Multimodal Analgesia (MMA) Protocol on patients undergoing Posterior Spinal Fusion. The purpose is to describe the narcotic requirements and usage during the perioperative period of posterior spinal fusion and instrumentation surgery with the implementation of multimodal anesthesia protocol. The study will consist of two parallel arms, with Group 1 receiving our MMA protocol and Group 2 receiving a traditional opioid-based regime. The primary outcome of this study will be the reported Visual Analog Scale (VAS) for pain at 12, 24, and 48 hours after surgery. We considered that our findings could contribute to the fight against the opioid crisis proving alternatives to opioids as feasible alternatives for pain management even in significant surgery, as is posterior spinal fusion with instrumentation.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Puerto Rico
• Treatments: Acetaminophen; Bupivacaine; Epinephrine; Gabapentin; Ketorolac Tromethamine; Lidocaine; Methylprednisolone; Morphine; Narcotics; Orphenadrine

Criteria

Inclusion Criteria:

• lumbar stenosis affecting L1-S1

• Requiring Posterior Spinal Fusion Surgery

• Age 30-85 years

Exclusion Criteria:

• younger than 30 years old or older than 85 years

• Chronic Renal Disease

• Hypersensitivity to any medication

• history of chronic opioid abuse.